Sec. 8. (a) For substitution to occur for a prescription other than a prescription filled under the Medicaid program (42 U.S.C. 1396 et seq.), the children's health insurance program established under IC 12-17.6-2 , the biosimilar biological products requirements under IC 16-42-25 , or the Medicare program (42 U.S.C. 1395 et seq.): (1) the practitioner must: (A) sign on the line under which the words "May substitute" appear; or (B) for an electronically transmitted prescription, electronically transmit the instruction "May substitute."; and (2) the pharmacist must inform the customer of the substitution. (b) This section does not authorize any substitution other than substitution of a generically equivalent drug product. [Pre-1993 Recodification Citation: 16-6-8.1-2(c).]
‹ Prev All Indiana sections Next ›
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.